Artemisinin, its semi-synthetic derivatives are a group of drugs used against Plasmodium falciparum malaria. It was discovered by Tu Youyou, a Chinese scientist, who was awarded half of the 2015 Nobel Prize in Medicine for her discovery. Treatments containing an artemisinin derivative (artemisinin-combination therapies, ACTs) are now standard treatment worldwide for P. falciparum malaria. Artemisinin is isolated from the plant Artemisia annua, sweet wormwood, a herb employed in Chinese traditional medicine. A precursor compound can be produced using genetically engineered yeast.
Prepared by an expert team, new research report on global Artemisinin market highlights recent developments, key trends, and new project developments in the market. This research, highlighting the current situation of the global market, focuses on answering some of the important questions faced by stakeholders.
Companies Profiled in this Report includes, Sanofi, KPC Pharmaceuticals, Inc, Guangxi Xiancaotang Pharmaceutical Co., LTD, Guilin Pharmaceutical Co., Ltd, Kerui Nanhai Pharmaceutical Co., Ltd, Shanghai Natural Bio-engineering Co., Ltd, PIDI Standard, Novanat Bioresource Co., Ltd, CATKHANH CO., Ltd, Botanical Extracts EPZ Ltd, BIONEXX
For Sample copy of this Report: https://goo.gl/BNu65U
By types, the market can be split into
Extraction from Artemisia Annua
Extraction from Engineered Organisms
By Application, the market can be split into
The global Artemisinin market from the perspective of all its current trends that are influencing it is important to understand in order to obtain the most rounded solution for business strategies in it. These trends are geographical, socioeconomic, economic, consumer, political, cultural, and their overall effect on client or consumer preferences will have a major data in how this market will form itself in the following years to come. Dynamics and the way they impact the global market have been studied in absolute precise details in the report. The ultimate goal for the dissemination of this information is to create a detailed descriptive analysis of how these trends could potentially affect the future of the global market within the report’s forecast period.
Reason to Access the Artemisinin Market Research Report:
This research, highlighting the current situation of the global Artemisinin market, focuses on answering some of the important questions faced by stakeholders. By providing answers to all of these questions related to the key drivers and dominant companies, the report’s authors also focus on different factors, which would create new growth opportunities in the global market. Prepared by an expert team, the report on the global market highlights recent developments, key trends, and new project developments in the market. As leading companies take efforts to maintain their dominance in the global market, the right way to do so is by adopting new technologies and strategies.
Analysis of Artemisinin market and its upcoming growth prospects is been mentioned with maximum precision. This study includes an elaborative summary of market which also includes snapshots that offer depth of information of various other segmentations. Through qualitative and quantitative analysis of key factors which are responsible for boosting or hampering the market growth and the promising opportunities in market have been provide.
Get Discount on This Premium Research now at: https://goo.gl/gavr6z
Table of Contents
Global Artemisinin Market Research Report 2017
Chapter 1 Artemisinin Market Overview
Chapter 2 Global Economic Impact on Industry
Chapter 3 Manufacturing Cost Analysis
Chapter 5 Global Competition by Manufacturers, Type and Application
Chapter 6 United States (Volume, Value and Sales Price)
Chapter 7 China (Volume, Value and Sales Price)
Chapter 8 Europe (Volume, Value and Sales Price)
Chapter 9 Japan (Volume, Value and Sales Price)
Chapter 10 Global Manufacturers Analysis
Chapter 11 Marketing Strategy Analysis, Distributors/Traders
Chapter 12 Market Effect Factors Analysis
Chapter 13 Global Market Forecast (2017-2021)